News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,630 Results
Type
Article (15099)
Company Profile (299)
Press Release (270226)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80860)
Career Advice (165)
Deals (13446)
Drug Delivery (39)
Drug Development (50840)
Employer Resources (31)
FDA (5925)
Job Trends (5280)
News (146589)
Policy (10301)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (936)
Accelerated approval (19)
Adcomms (14)
Allergies (87)
Alliances (22016)
ALS (124)
Alzheimer's disease (1033)
Antibody-drug conjugate (ADC) (241)
Approvals (6118)
Artificial intelligence (260)
Autoimmune disease (110)
Automation (9)
Bankruptcy (111)
Best Places to Work (4667)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (103)
Brain cancer (46)
Breast cancer (345)
Cancer (3144)
Cardiovascular disease (238)
Career advice (150)
Career pathing (7)
CAR-T (218)
CDC (6)
Cell therapy (565)
Cervical cancer (14)
Clinical research (43768)
Collaboration (1150)
Company closure (2)
Compensation (592)
Complete response letters (39)
COVID-19 (1120)
CRISPR (86)
C-suite (552)
Cystic fibrosis (112)
Data (4335)
Denatured (15)
Depression (93)
Diabetes (257)
Diagnostics (1433)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (52)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31976)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52056)
Executive appointments (627)
FDA (7687)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (984)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (505)
Government (1192)
Grass and pollen (3)
Guidances (170)
Healthcare (6850)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (66)
Infectious disease (1226)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (166)
Interviews (20)
IPO (7399)
IRA (12)
Job creations (873)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (248)
Leadership (10)
Legal (1477)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (381)
MASH (130)
Medical device (2840)
Medtech (2849)
Mergers & acquisitions (6673)
Metabolic disorders (728)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (71)
Neuroscience (1953)
Neurotech (1)
NextGen: Class of 2026 (2124)
Non-profit (977)
Now hiring (30)
Obesity (330)
Opinion (131)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (12)
Patents (303)
Patient recruitment (328)
Peanut (43)
People (26997)
Pharmaceutical (44)
Pharmacy benefit managers (7)
Phase 1 (15507)
Phase 2 (20319)
Phase 3 (12858)
Pipeline (3265)
Policy (96)
Postmarket research (857)
Preclinical (6560)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (647)
Real estate (1466)
Recruiting (12)
Regulatory (10019)
Reports (19)
Research institute (985)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2015)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (22)
The Weekly (62)
Vaccines (339)
Venture capital (70)
Weight loss (173)
Women's health (27)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1213)
Last 365 days (17911)
2026 (1661)
2025 (18211)
2024 (20653)
2023 (22602)
2022 (27053)
2021 (28073)
2020 (23848)
2019 (16684)
2018 (12109)
2017 (13920)
2016 (12041)
2015 (14488)
2014 (10508)
2013 (7555)
2012 (7622)
2011 (7732)
2010 (7523)
Location
Africa (156)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (5)
Asia (18360)
Australia (3133)
California (7112)
Canada (1840)
China (772)
Colorado (247)
Connecticut (252)
Delaware (236)
Europe (39498)
Florida (911)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (414)
India (35)
Indiana (161)
Iowa (8)
Japan (222)
Kansas (81)
Kentucky (9)
Louisiana (8)
Maine (13)
Maryland (740)
Massachusetts (5589)
Michigan (110)
Minnesota (250)
Mississippi (3)
Missouri (38)
Montana (16)
Nebraska (6)
Nevada (41)
New Hampshire (21)
New Jersey (1647)
New Mexico (13)
New York (1771)
North Carolina (826)
North Dakota (6)
Northern California (3490)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1284)
Puerto Rico (9)
Rhode Island (25)
South America (234)
South Carolina (9)
Southern California (2813)
Tennessee (40)
Texas (907)
United States (23450)
Utah (101)
Virginia (137)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
285,630 Results for "shield therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program
January 7, 2026
·
5 min read
Press Releases
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
November 5, 2025
·
5 min read
Press Releases
PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress
October 1, 2025
·
4 min read
Press Releases
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
September 5, 2025
·
4 min read
Press Releases
Cayman Chemical and Curapath Partner to Provide Wider Access to PEG-Free Shielding Lipids for Lipid Nanoparticles
September 3, 2025
·
1 min read
Press Releases
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
September 25, 2025
·
6 min read
Genetown
Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
Cimeio Therapeutics today announced a publication in Nature showing that its CD45 antibody-drug conjugate (ADC) eradicated aggressive leukemic cells in vivo, while hematopoiesis was fully preserved and protected from the ADC via shielded hematopoietic stem cells (HSCs).
May 22, 2024
·
3 min read
Press Releases
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
July 15, 2025
·
5 min read
Press Releases
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
June 9, 2025
·
12 min read
Press Releases
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
June 17, 2025
·
6 min read
1 of 28,563
Next
